Abstract:Background: The goal of this study was to screen for differentially expressed exosomal miRNAs in peripheral blood samples of early-onset preeclampsia and normal pregnant patients using high-throughput sequencing methods and explore their effects on the pathogenesis of preeclampsia. Methods: Peripheral blood samples from 5 patients with early-onset preeclampsia and 5 normal pregnant women (control group) were enrolled. Then, exosomes were extracted from each sample, and the procedure was replicated three times. An Illumina HiSeq4000 sequencing platform was used to analyze exosomal miRNAs in all samples before comparison. The target genes and signaling pathway predictions and the biological function enrichments of significant and differentially expressed miRNAs were assessed using Miranda and Starbase software, as well as GO and KEGG databases. Results: Compared with the control, patients in the early-onset preeclampsia group had 65 significantly and differentially expressed exosomal miRNAs in their peripheral blood samples. The results have shown that of the 65 differentially expressed miRNAs, 17, including has-miR-6855, has-miR-7151, and has-miR-6777, were up-regulated, and 48, including has-miR-1247, has-miR-29B2, and has-miR-941, were down-regulated (p < 0.05). The Miranda and TargetScanS algorithms predicted a total of 2,231 target genes from the differentially expressed miRNAs. The Go and KEGG analyses showed that the principal biological function of these target genes was the regulation of Ras protein signal transduction, histone modification, GTPase-mediated signal transduction, and transforming growth factor (TGF)-β. Additionally, the results also showed that the major pathways involved in the regulation of these functions were the PI3K Akt, MAPK, tumor necrosis factor, and EGFR tyrosine kinase inhibition signaling pathways. Conclusions: There are significant differences in the expression profiles of exosomal miRNAs between early-onset preeclampsia patients and normal pregnant women. These differentially expressed miRNAs may not only play an important regulatory role in the occurrence of early-onset preeclampsia but also participate in its pathophysiological process through genetic regulation of a variety of biological functions and signal pathways.

Placenta-Specific Circulating Mircornas and Their Variants As Potential Biomarkers for Preeclampsia

Integrative Analysis of Circulating Micrornas and the Placental Transcriptome in Recurrent Pregnancy Loss

Variations of MicroRNAs in Human Placentas and Plasma from Preeclamptic Pregnancy

Deregulated microRNA species in the plasma and placenta of patients with preeclampsia.

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

Maternal Plasma Mirnas Expression in Preeclamptic Pregnancies

Small RNA sequencing reveals placenta-derived exosomal microRNAs associated with preeclampsia

Application of Next-Generation Sequencing Technology to Profile the Circulating Micrornas in the Serum of Preeclampsia Versus Normal Pregnant Women

Differential Expression Of Micrornas In The Placentae Of Chinese Patients With Severe Pre-Eclampsia

Comparative Quantification Of Microrna In Placenta And Circulating Nucleic Acid Isolated From Maternal Plasma And Umbilical Cord Plasma

Pathogenic Mechanisms of Preeclampsia with Severe Features Implied by the Plasma Exosomal Mirna Profile

Circulating Micrornas As Biomarkers for Diagnosis and Prediction of Preeclampsia: A Systematic Review and Meta-Analysis

Elevated Placental microRNA-155 Is a Biomarker of a Preeclamptic Subtype

Quantification of Preeclampsia-Related Micrornas in Maternal Serum.

Placental Mir-106A∼363 Cluster is Dysregulated in Preeclamptic Placenta.

Chimeric RNA landscape in the placenta: A transcriptomic analysis revealing novel diagnostic biomarkers for preeclampsia

A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing.

miR-31-5p from placental and peripheral blood exosomes is a potential biomarker to diagnose preeclampsia

Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology

Downregulations of Circulating Mir-31 and Mir-21 Are Associated with Preeclampsia.

High Throughput Sequencing Analysis of Exosomal miRNA Expressions in Early-Onset Preeclampsia Patients